Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 100
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Blood ; 142(11): 989-1007, 2023 09 14.
Artículo en Inglés | MEDLINE | ID: mdl-37172199

RESUMEN

Dysregulation of innate immune signaling is a hallmark of hematologic malignancies. Recent therapeutic efforts to subvert aberrant innate immune signaling in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) have focused on the kinase IRAK4. IRAK4 inhibitors have achieved promising, though moderate, responses in preclinical studies and clinical trials for MDS and AML. The reasons underlying the limited responses to IRAK4 inhibitors remain unknown. In this study, we reveal that inhibiting IRAK4 in leukemic cells elicits functional complementation and compensation by its paralog, IRAK1. Using genetic approaches, we demonstrate that cotargeting IRAK1 and IRAK4 is required to suppress leukemic stem/progenitor cell (LSPC) function and induce differentiation in cell lines and patient-derived cells. Although IRAK1 and IRAK4 are presumed to function primarily downstream of the proximal adapter MyD88, we found that complementary and compensatory IRAK1 and IRAK4 dependencies in MDS/AML occur via noncanonical MyD88-independent pathways. Genomic and proteomic analyses revealed that IRAK1 and IRAK4 preserve the undifferentiated state of MDS/AML LSPCs by coordinating a network of pathways, including ones that converge on the polycomb repressive complex 2 complex and JAK-STAT signaling. To translate these findings, we implemented a structure-based design of a potent and selective dual IRAK1 and IRAK4 inhibitor KME-2780. MDS/AML cell lines and patient-derived samples showed significant suppression of LSPCs in xenograft and in vitro studies when treated with KME-2780 as compared with selective IRAK4 inhibitors. Our results provide a mechanistic basis and rationale for cotargeting IRAK1 and IRAK4 for the treatment of cancers, including MDS/AML.


Asunto(s)
Leucemia Mieloide Aguda , Síndromes Mielodisplásicos , Humanos , Quinasas Asociadas a Receptores de Interleucina-1/genética , Quinasas Asociadas a Receptores de Interleucina-1/metabolismo , Factor 88 de Diferenciación Mieloide/genética , Factor 88 de Diferenciación Mieloide/metabolismo , Proteómica , Transducción de Señal , Síndromes Mielodisplásicos/tratamiento farmacológico , Síndromes Mielodisplásicos/genética , Leucemia Mieloide Aguda/genética
2.
Haematologica ; 108(10): 2715-2729, 2023 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-37102608

RESUMEN

Inflammation is associated with the pathogenesis of myelodysplastic syndromes (MDS) and emerging evidence suggests that MDS hematopoietic stem and progenitor cells (HSPC) exhibit an altered response to inflammation. Deletion of chromosome 5 (del(5q)) is the most common chromosomal abnormality in MDS. Although this MDS subtype contains several haploinsufficient genes that impact innate immune signaling, the effects of inflammation on del(5q) MDS HSPC remains undefined. Utilizing a model of del(5q)-like MDS, inhibiting the IRAK1/4-TRAF6 axis improved cytopenias, suggesting that activation of innate immune pathways contributes to certain clinical features underlying the pathogenesis of low-risk MDS. However, low-grade inflammation in the del(5q)-like MDS model did not contribute to more severe disease but instead impaired the del(5q)-like HSPC as indicated by their diminished numbers, premature attrition and increased p53 expression. Del(5q)-like HSPC exposed to inflammation became less quiescent, but without affecting cell viability. Unexpectedly, the reduced cellular quiescence of del(5q) HSPC exposed to inflammation was restored by p53 deletion. These findings uncovered that inflammation confers a competitive advantage of functionally defective del(5q) HSPC upon loss of p53. Since TP53 mutations are enriched in del(5q) AML following an MDS diagnosis, increased p53 activation in del(5q) MDS HSPC due to inflammation may create a selective pressure for genetic inactivation of p53 or expansion of a pre-existing TP53-mutant clone.


Asunto(s)
Síndromes Mielodisplásicos , Proteína p53 Supresora de Tumor , Humanos , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/metabolismo , Deleción Cromosómica , Síndromes Mielodisplásicos/patología , Células Madre Hematopoyéticas/metabolismo , Transducción de Señal , Cromosomas Humanos Par 5/genética , Cromosomas Humanos Par 5/metabolismo
3.
Artículo en Inglés | MEDLINE | ID: mdl-37486956

RESUMEN

ABSTRACT: In the field of forensic medicine, estimating time since death plays an important role in helping the investigative organizations unravel the mystery of crime. Presently, many less reliable subjective parameters are being used to measure it, necessitating the need to have more specific and objective parameters. This cross-sectional comparative study was conducted at the Department of Forensic Medicine and Toxicology, All India Institute of Medical Sciences, Bhopal, India on 60 deceased bodies to determine the correlation between known time since death and biochemical parameters in the synovial fluid specifically sodium, potassium, lactate, and total proteins, analyzed using random access fully automated chemical analyzer (Beckman Coulter Au680) followed by estimation of correlation using Spearman correlation test.All the biochemical parameters that were tested in the synovial fluid except for sodium showed a significant correlation. The potassium and lactate showed a significant positive correlation (P < 0.001), and on the contrary, the total protein level showed a significant negative correlation with time since death (P < 0.001). This study shows usefulness of these markers in estimating the time since death. The smaller sample size and the unavailability of the results of effect of cold storage on these parameters necessitate the need of further similar studies to uncover the real practical application.

4.
Risk Anal ; 42(8): 1728-1748, 2022 08.
Artículo en Inglés | MEDLINE | ID: mdl-33190276

RESUMEN

Social media has been increasingly utilized to spread breaking news and risk communications during disasters of all magnitudes. Unfortunately, due to the unmoderated nature of social media platforms such as Twitter, rumors and misinformation are able to propagate widely. Given this, a surfeit of research has studied false rumor diffusion on Twitter, especially during natural disasters. Within this domain, studies have also focused on the misinformation control efforts from government organizations and other major agencies. A prodigious gap in research exists in studying the monitoring of misinformation on social media platforms in times of disasters and other crisis events. Such studies would offer organizations and agencies new tools and ideologies to monitor misinformation on platforms such as Twitter, and make informed decisions on whether or not to use their resources in order to debunk. In this work, we fill the research gap by developing a machine learning framework to predict the veracity of tweets that are spread during crisis events. The tweets are tracked based on the veracity of their content as either true, false, or neutral. We conduct four separate studies, and the results suggest that our framework is capable of tracking multiple cases of misinformation simultaneously, with F 1 $F_1$ scores exceeding 87%. In the case of tracking a single case of misinformation, our framework reaches an F 1 $F_1$ score of 83%. We collect and drive the algorithms with 15,952 misinformation-related tweets from the Boston Marathon bombing (2013), Manchester Arena bombing (2017), Hurricane Harvey (2017), Hurricane Irma (2017), and the Hawaii ballistic missile false alert (2018). This article provides novel insights on how to efficiently monitor misinformation that is spread during disasters.


Asunto(s)
Medios de Comunicación Sociales , Comunicación , Humanos , Aprendizaje Automático
5.
Risk Anal ; 41(12): 2356-2391, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34056745

RESUMEN

Risk-informed asset management is key to maintaining optimal performance and efficiency of urban sewer systems. Although sewer system failures are spatiotemporal in nature, previous studies analyzed failure risk from a unidimensional aspect (either spatial or temporal), not accounting for bidimensional spatiotemporal complexities. This is owing to the insufficiency of good-quality data, which ultimately leads to under-/overestimation of failure risk. Here, we propose a generalized methodology/framework to facilitate a robust spatiotemporal analysis of urban sewer system failure risk, overcoming the intrinsic challenges of data imperfections-e.g., missing data, outliers, and imbalanced information. The framework includes a two-stage data-driven modeling technique that efficiently models the highly right-skewed sewer system failure data to predict the failure risk, leveraging a bidimensional space-time approach. We implemented our analysis for Bogotá, the capital city of Colombia. We train, test, and validate a battery of machine learning algorithms-logistic regression, decision trees, random forests, and XGBoost-and select the best model in terms of goodness-of-fit and predictive accuracy. Finally, we illustrate the applicability of the framework in planning/scheduling sewer system maintenance operations using state-of-the-art optimization techniques. Our proposed framework can help stakeholders to analyze the failure-risk models' performance under different discrimination thresholds, and provide managerial insights on the model's adequate spatial resolution and appropriateness of decentralized management for sewer system maintenance.

6.
Eur J Neurosci ; 51(12): 2394-2411, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-31883161

RESUMEN

Brain-derived neurotrophic factor (BDNF) could be considered a potential neuroprotective therapy in amyloid beta (Aß)-associated retinal and optic nerve degeneration. Hence, in this study we investigated the neuroprotective effect of BDNF against Aß1-40-induced retinal and optic nerve injury. In this study, exposure to Aß1-40 was associated with retinal and optic nerve injury. TUNEL staining showed significant reduction in the apoptotic cell count in the BDNF-treated group compared with Aß1-40 group. H&E-stained retinal sections also showed a striking reduction in neuronal cells in the ganglion cell layer (GCL) of retinas fourteen days after Aß1-40 exposure. By contrast, number of retinal cells was preserved in the retinas of BDNF-treated animals. After Aß1-40 exposure, visible axonal swelling was observed in optic nerve sections. However, the BDNF-treated group showed fewer changes in optic nerve; axonal swelling was less frequent and less marked. In the present study, exposure to Aß was associated with oxidative stress, whereas levels of retinal glutathione (GSH), superoxide dismutase (SOD) and catalase were significantly increased in BDNF-treated than in Aß1-40-treated rats. Both visual object recognition tests using an open-field arena and a Morris water maze showed that BDNF improved rats' ability to recognise visual cues (objects with different shapes) after Aß1-40 exposure, thus demonstrating that the visual performance of rats was relatively preserved following BDNF treatment. In conclusion, intravitreal treatment with BDNF prevents Aß1-40-induced retinal cell apoptosis and axon loss in the optic nerve of rats by reducing retinal oxidative stress and restoring retinal BDNF levels.


Asunto(s)
Fármacos Neuroprotectores , Traumatismos del Nervio Óptico , Péptidos beta-Amiloides/toxicidad , Animales , Factor Neurotrófico Derivado del Encéfalo , Fármacos Neuroprotectores/farmacología , Nervio Óptico , Traumatismos del Nervio Óptico/tratamiento farmacológico , Ratas , Ratas Sprague-Dawley , Células Ganglionares de la Retina
7.
Exp Eye Res ; 194: 107996, 2020 05.
Artículo en Inglés | MEDLINE | ID: mdl-32156652

RESUMEN

Endothelin-1 (ET-1), a potent vasoconstrictor, plays a significant role in the pathophysiology of ocular conditions like glaucoma. Glaucoma is characterized by apoptotic loss of retinal ganglion cells (RGCs) and loss of visual fields and is a leading cause of irreversible blindness. In glaucomatous eyes, retinal ischemia causes release of pro-inflammatory mediators such as interleukin (IL)-1ß, IL-6 and tumor necrosis factor (TNF)-α and promotes activation of transcription factors such as nuclear factor kappa B (NFKB) and c-Jun. Magnesium acetyltaurate (MgAT) has previously been shown to protect against ET-1 induced retinal and optic nerve damage. Current study investigated the mechanisms underlying these effects of MgAT, which so far remain unknown. Sprague dawley rats were intravitreally injected with ET-1 with or without pretreatment with MgAT. Seven days post-injection, retinal expression of IL-1ß, IL-6, TNF-α, NFKB and c-Jun protein and genes was determined using multiplex assay, Western blot and PCR. Animals were subjected to retrograde labeling of RGCs to determine the extent of RGC survival. RGC survival was also examined using Brn3A staining. Furthermore, visual functions of rats were determined using Morris water maze. It was observed that pre-treatment with MgAT protects against ET-1 induced increase in the retinal expression of IL-1ß, IL-6 and TNF-α proteins and genes. It also protected against ET-1 induced activation of NFKB and c-Jun. These effects of MgAT were associated with greater RGC survival and preservation of visual functions in rats. In conclusion, MgAT prevents ET-1 induced RGC loss and loss of visual functions by suppressing neuroinflammatory reaction in rat retinas.


Asunto(s)
Glaucoma/patología , Enfermedades de la Retina/prevención & control , Células Ganglionares de la Retina/efectos de los fármacos , Taurina/análogos & derivados , Agudeza Visual , Animales , Apoptosis/efectos de los fármacos , Western Blotting , Modelos Animales de Enfermedad , Endotelina-1/toxicidad , Femenino , Glaucoma/complicaciones , Inyecciones Intravítreas , Masculino , Pronóstico , Ratas , Ratas Sprague-Dawley , Enfermedades de la Retina/etiología , Enfermedades de la Retina/patología , Células Ganglionares de la Retina/patología , Taurina/administración & dosificación
8.
Risk Anal ; 40(7): 1438-1449, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32339319

RESUMEN

The objective of this article is to study the impact of weather on the damage caused by fire incidents across the United States. The article uses two sets of big data--fire incidents data from the National Fire Incident Reporting System (NFIRS) and weather data from the National Oceanic and Atmospheric Administration (NOAA)-to obtain a single comprehensive data set for prediction and analysis of fire risk. In the article, the loss is referred to as "Total Percent Loss," a metric that is calculated based on the content and property loss incurred by an owner over the total value of content and property. Gradient boosting tree (GBT), a machine learning algorithm, is implemented on the processed data to predict the losses due to fire incidents. An R2 value of 0.933 and mean squared error (MSE) of 124.641 out of 10,000 signify the extent of high predictive accuracy obtained by implementing the GBT model. In addition to this, an excellent predictive performance demonstrated by the GBT model is further validated by a strong fitting between the predicted loss and the actual loss for the test data set, with an R2 value of 0.97. While analyzing the influence of each input variable on the output, it is observed that the state in which a fire incident takes place plays a major role in determining fire risk. This article provides useful insights to fire managers and researchers in the form of a detailed framework of big data and predictive analytics for effective management of fire risk.

9.
Blood ; 129(8): 1008-1020, 2017 02 23.
Artículo en Inglés | MEDLINE | ID: mdl-28011678

RESUMEN

Tyrosine kinase inhibitor (TKI) treatment of chronic myeloid leukemia (CML) has limited efficacy against leukemia stem cells (LSC) responsible for disease propagation, and most CML patients require continued TKI treatment to maintain remission. LSC maintenance is related, at least in part, to signals from the bone marrow microenvironment (BMM). Our previous studies have shown that Wnt signaling from the BMM contributes to preservation of CML LSC following TKI treatment. Secretion of Wnt ligands requires their modification by the O-acyl transferase Porcupine (PORCN). Here we investigated the activity of a potent and selective PORCN inhibitor, WNT974, against CML stem and progenitor cells. WNT974 efficiently antagonized Wnt signaling in human CML CD34+ cells, and in combination with the TKI nilotinib (NIL) significantly enhanced inhibition of proliferation and colony-forming potential of CML stem and progenitor cells and reduced their growth in immunodeficient mice in vivo, in comparison with NIL alone. Treatment of transgenic CML mice in vivo with NIL in combination with WNT974 significantly reduced leukemic stem and progenitor cell numbers, reduced regeneration of leukemic long-term hematopoietic stem cells in secondary transplant recipients, and enhanced survival of mice after discontinuation of treatment, in comparison with NIL alone. CML progenitors demonstrated enhanced sensitivity to Wnt stimulation, associated with increased expression of the FZD4 receptor. FZD4 knockdown inhibited CML progenitor growth. These results support further investigation of PORCN targeting to inhibit Wnt secretion and signaling and enhance targeting of CML stem cells while sparing their normal counterparts.


Asunto(s)
Antineoplásicos/uso terapéutico , Proliferación Celular/efectos de los fármacos , Inhibidores Enzimáticos/uso terapéutico , Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Proteínas de la Membrana/antagonistas & inhibidores , Células Madre Neoplásicas/efectos de los fármacos , Proteínas Tirosina Quinasas/antagonistas & inhibidores , Aciltransferasas , Animales , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Células Cultivadas , Inhibidores Enzimáticos/farmacología , Humanos , Leucemia Mielógena Crónica BCR-ABL Positiva/metabolismo , Leucemia Mielógena Crónica BCR-ABL Positiva/patología , Proteínas de la Membrana/metabolismo , Ratones Transgénicos , Células Madre Neoplásicas/metabolismo , Células Madre Neoplásicas/patología , Inhibidores de Proteínas Quinasas/farmacología , Inhibidores de Proteínas Quinasas/uso terapéutico , Proteínas Tirosina Quinasas/metabolismo , Pirimidinas/farmacología , Pirimidinas/uso terapéutico , Células Tumorales Cultivadas , Vía de Señalización Wnt/efectos de los fármacos
10.
Amino Acids ; 51(4): 641-646, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-30656415

RESUMEN

This study aimed to evaluate effect of TAU on NMDA-induced changes in retinal redox status, retinal cell apoptosis and retinal morphology in Sprague-Dawley rats. Taurine was injected intravitreally as pre-, co- or post-treatment with NMDA and 7 days post-treatment retinae were processed for estimation of oxidative stress, retinal morphology using H&E staining and retinal cell apoptosis using TUNEL staining. Treatment with TAU, particularly pre-treatment, significantly increased retinal glutathione, superoxide dismutase and catalase levels compared to NMDA-treated rats; whereas, the levels of malondialdehyde reduced significantly. Reduction in retinal oxidative stress in TAU pre-treated group was associated with significantly greater fractional thickness of ganglion cell layer within inner retina and retinal cell density in inner retina. TUNEL staining showed significantly reduced apoptotic cell count in TAU pre-treated group compared to NMDA group. It could be concluded that TAU protects against NMDA-induced retinal injury in rats by reducing retinal oxidative stress.


Asunto(s)
Agonistas de Aminoácidos Excitadores/toxicidad , N-Metilaspartato/toxicidad , Estrés Oxidativo/efectos de los fármacos , Sustancias Protectoras/farmacología , Enfermedades de la Retina/tratamiento farmacológico , Retinaldehído/metabolismo , Taurina/farmacología , Animales , Apoptosis/efectos de los fármacos , Femenino , Masculino , Oxidación-Reducción , Ratas , Ratas Sprague-Dawley , Enfermedades de la Retina/inducido químicamente , Enfermedades de la Retina/metabolismo , Enfermedades de la Retina/patología
11.
Mol Vis ; 24: 495-508, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30090013

RESUMEN

Purpose: Retinal nitrosative stress associated with altered expression of nitric oxide synthases (NOS) plays an important role in excitotoxic retinal ganglion cell loss in glaucoma. The present study evaluated the effects of magnesium acetyltaurate (MgAT) on changes induced by N-methyl-D-aspartate (NMDA) in the retinal expression of three NOS isoforms, retinal 3-nitrotyrosine (3-NT) levels, and the extent of retinal cell apoptosis in rats. Effects of MgAT with taurine (TAU) alone were compared to understand the benefits of a combined salt of Mg and TAU. Methods: Excitotoxic retinal injury was induced with intravitreal injection of NMDA in Sprague-Dawley rats. All treatments were given as pre-, co-, and post-treatment with NMDA. Seven days post-injection, the retinas were processed for measurement of the expression of NOS isoforms using immunostaining and enzyme-linked immunosorbent assay (ELISA), retinal 3-NT content using ELISA, retinal histopathological changes using hematoxylin and eosin (H&E) staining, and retinal cell apoptosis using terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) staining. Results: As observed on immunohistochemistry, the treatment with NMDA caused a 4.53-fold increase in retinal nNOS expression compared to the PBS-treated rats (p<0.001). Among the MgAT-treated groups, only the pretreatment group showed significantly lower nNOS expression than the NMDA-treated group with a 2.00-fold reduction (p<0.001). Among the TAU-treated groups, the pre- and cotreatment groups showed 1.84- and 1.71-fold reduction in nNOS expression compared to the NMDA-treated group (p<0.001), respectively, but remained higher compared to the PBS-treated group (p<0.01). Similarly, iNOS expression in the NMDA-treated group was significantly greater than that for the PBS-treated group (2.68-fold; p<0.001). All MgAT treatment groups showed significantly lower iNOS expression than the NMDA-treated groups (3.58-, 1.51-, and 1.65-folds, respectively). However, in the MgAT co- and post-treatment groups, iNOS expression was significantly greater than in the PBS-treated group (1.77- and 1.62-folds, respectively). Pretreatment with MgAT caused 1.77-fold lower iNOS expression compared to pretreatment with TAU (p<0.05). In contrast, eNOS expression was 1.63-fold higher in the PBS-treated group than in the NMDA-treated group (p<0.001). Among all treatment groups, only pretreatment with MgAT caused restoration of retinal eNOS expression with a 1.39-fold difference from the NMDA-treated group (p<0.05). eNOS expression in the MgAT pretreatment group was also 1.34-fold higher than in the TAU pretreatment group (p<0.05). The retinal NOS expression as measured with ELISA was in accordance with that estimated with immunohistochemistry. Accordingly, among the MgAT treatment groups, only the pretreated group showed 1.47-fold lower retinal 3-NT than the NMDA-treated group, and the difference was significant (p<0.001). The H&E-stained retinal sections in all treatment groups showed statistically significantly greater numbers of retinal cell nuclei than the NMDA-treated group in the inner retina. However, the ganglion cell layer thickness in the TAU pretreatment group remained 1.23-fold lower than that in the MgAT pretreatment group (p<0.05). In line with this observation, the number of apoptotic cells as observed after TUNEL staining was 1.69-fold higher after pretreatment with TAU compared to pretreatment with MgAT (p<0.01). Conclusions: MgAT and TAU, particularly with pretreatment, reduce retinal cell apoptosis by reducing retinal nitrosative stress. Pretreatment with MgAT caused greater improvement in NMDA-induced changes in iNOS and eNOS expression and retinal 3-NT levels than pretreatment with TAU. The greater reduction in retinal nitrosative stress after pretreatment with MgAT was associated with lower retinal cell apoptosis and greater preservation of the ganglion cell layer thickness compared to pretreatment with TAU.


Asunto(s)
Regulación de la Expresión Génica/efectos de los fármacos , N-Metilaspartato/antagonistas & inhibidores , Fármacos Neuroprotectores/farmacología , Células Ganglionares de la Retina/efectos de los fármacos , Taurina/análogos & derivados , Taurina/farmacología , Animales , Apoptosis/efectos de los fármacos , Esquema de Medicación , Inyecciones Intravítreas , Masculino , N-Metilaspartato/efectos adversos , Óxido Nítrico Sintasa de Tipo I/genética , Óxido Nítrico Sintasa de Tipo I/metabolismo , Óxido Nítrico Sintasa de Tipo II/genética , Óxido Nítrico Sintasa de Tipo II/metabolismo , Óxido Nítrico Sintasa de Tipo III/genética , Óxido Nítrico Sintasa de Tipo III/metabolismo , Estrés Nitrosativo/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Células Ganglionares de la Retina/metabolismo , Células Ganglionares de la Retina/patología , Transducción de Señal , Tirosina/análogos & derivados , Tirosina/antagonistas & inhibidores , Tirosina/metabolismo
12.
Blood ; 128(23): 2671-2682, 2016 12 08.
Artículo en Inglés | MEDLINE | ID: mdl-27621307

RESUMEN

Treatment of chronic myelogenous leukemia (CML) with BCR-ABL tyrosine kinase inhibitors (TKI) fails to eliminate leukemia stem cells (LSC). Patients remain at risk for relapse, and additional approaches to deplete CML LSC are needed to enhance the possibility of discontinuing TKI treatment. We have previously reported that expression of the pivotal proinflammatory cytokine interleukin-1 (IL-1) is increased in CML bone marrow. We show here that CML LSC demonstrated increased expression of the IL-1 receptors, IL-1 receptor accessory protein and IL-1 receptor type 1 (IL-1R1), and enhanced sensitivity to IL-1-induced NF-κB signaling compared with normal stem cells. Treatment with recombinant IL-1 receptor antagonist (IL-1RA) inhibited IL-1 signaling in CML LSC and inhibited growth of CML LSC. Importantly, the combination of IL-1RA with TKI resulted in significantly greater inhibition of CML LSC compared with TKI alone. Our studies also suggest that IL-1 signaling contributes to overexpression of inflammatory mediators in CML LSC, suggesting that blocking IL-1 signaling could modulate the inflammatory milieu. We conclude that IL-1 signaling contributes to maintenance of CML LSC following TKI treatment and that IL-1 blockade with IL-1RA enhances elimination of TKI-treated CML LSC. These results provide a strong rationale for further exploration of anti-IL-1 strategies to enhance LSC elimination in CML.


Asunto(s)
Interleucina-1/metabolismo , Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Proteínas de Neoplasias/metabolismo , Células Madre Neoplásicas/metabolismo , Inhibidores de Proteínas Quinasas/farmacología , Transducción de Señal/efectos de los fármacos , Animales , Humanos , Proteína Antagonista del Receptor de Interleucina 1/metabolismo , Leucemia Mielógena Crónica BCR-ABL Positiva/metabolismo , Leucemia Mielógena Crónica BCR-ABL Positiva/patología , Ratones , Células Madre Neoplásicas/patología , Receptores Tipo I de Interleucina-1/metabolismo
13.
Int J Neurosci ; 128(10): 952-965, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29488424

RESUMEN

PURPOSE: Amyloid beta (Aß) is known to contribute to the pathophysiology of retinal neurodegenerative diseases such as glaucoma. Effects of intravitreal Aß(1-42) on retinal and optic nerve morphology in animal models have widely been studied but not those of Aß(1-40). Hence, we evaluated the time- and dose-related effects of intravitreal Aß(1-40) on retinal and optic nerve morphology. Since oxidative stress and brain derived neurotrophic factor (BDNF) are associated with Aß-induced neuronal damage, we also studied dose and time-related effects of Aß(1-40) on retinal oxidative stress and BDNF levels. MATERIALS AND METHODS: Five groups of rats were intravitreally administered with vehicle or Aß(1-40) in doses of 1.0, 2.5, 5 and 10 nmol. Animals were sacrificed and eyes were enucleated at weeks 1, 2 and 4 post-injection. The retinae were subjected to morphometric analysis and TUNEL staining. Optic nerve sections were stained with toluidine blue and were graded for neurodegenerative effects. The estimation of BDNF and markers of oxidative stress in retina were done using ELISA technique. RESULTS AND CONCLUSIONS: It was observed that intravitreal Aß(1-40) causes significant retinal and optic nerve damage up to day 14 post-injection and there was increasing damage with increase in dose. However, on day 30 post-injection both the retinal and optic nerve morphology showed a trend towards normalization. The observations made for retinal cell apoptosis, retinal glutathione, superoxide dismutase activity and BDNF were in accordance with those of morphological changes with deterioration till day 14 and recovery by day 30 post-injection. The findings of this study may provide a guide for selection of appropriate experimental conditions for future studies.


Asunto(s)
Péptidos beta-Amiloides/toxicidad , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Nervio Óptico , Estrés Oxidativo/efectos de los fármacos , Fragmentos de Péptidos/toxicidad , Retina , Péptidos beta-Amiloides/administración & dosificación , Animales , Etiquetado Corte-Fin in Situ , Nervio Óptico/efectos de los fármacos , Nervio Óptico/metabolismo , Nervio Óptico/patología , Fragmentos de Péptidos/administración & dosificación , Ratas , Ratas Sprague-Dawley , Retina/efectos de los fármacos , Retina/metabolismo , Retina/patología , Cuerpo Vítreo/efectos de los fármacos
14.
J Neurovirol ; 23(3): 501-503, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28105556

RESUMEN

Chikungunya fever is an Aedes mosquito-transmitted infection caused by chikungunya virus, an RNA virus in the family Togaviridae. The disease is characteristically manifested as fever, arthralgia, and/or rash. Various neurological manifestations like meningoencephalitis, myelitis, and myeloneuropathy have been mentioned in various reports. We present a rare case of chikungunya fever presenting with mild encephalitis with a reversible lesion of the splenium (MERS), which showed complete clinical and radiological recovery.


Asunto(s)
Fiebre Chikungunya/diagnóstico por imagen , Virus Chikungunya/genética , Cuerpo Calloso/diagnóstico por imagen , Encefalitis Viral/diagnóstico por imagen , ARN Viral/genética , Fiebre Chikungunya/patología , Fiebre Chikungunya/terapia , Fiebre Chikungunya/virología , Virus Chikungunya/aislamiento & purificación , Cuerpo Calloso/patología , Cuerpo Calloso/virología , Diagnóstico Diferencial , Encefalitis Viral/patología , Encefalitis Viral/terapia , Encefalitis Viral/virología , Fluidoterapia , Escala de Coma de Glasgow , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa
15.
Blood ; 125(17): 2678-88, 2015 Apr 23.
Artículo en Inglés | MEDLINE | ID: mdl-25742698

RESUMEN

Hematopoietic stem cells (HSCs) reside in regulatory niches in the bone marrow (BM). Although HSC niches have been extensively characterized, the role of endosteal osteoblasts (OBs) in HSC regulation requires further clarification, and the role of OBs in regulating leukemic stem cells (LSCs) is not well studied. We used an OB visualization and ablation mouse model to study the role of OBs in regulating normal HSCs and chronic myelogenous leukemia (CML) LSCs. OB ablation resulted in increase in cells with a LSK Flt3(-)CD150(+)CD48(-) long-term HSC (LTHSC) phenotype but reduction of a more highly selected LSK Flt3(-)CD34(-)CD49b(-)CD229(-) LTHSC subpopulation. LTHSCs from OB-ablated mice demonstrated loss of quiescence and reduced long-term engraftment and self-renewal capacity. Ablation of OB in a transgenic CML mouse model resulted in accelerated leukemia development with reduced survival compared with control mice. The notch ligand Jagged-1 was overexpressed on CML OBs. Normal and CML LTHSCs cultured with Jagged-1 demonstrated reduced cell cycling, consistent with a possible role for loss of Jagged-1 signals in altered HSC and LSC function after OB ablation. These studies support an important role for OBs in regulating quiescence and self-renewal of LTHSCs and a previously unrecognized role in modulating leukemia development in CML.


Asunto(s)
Células Madre Hematopoyéticas/citología , Leucemia Mielógena Crónica BCR-ABL Positiva/patología , Células Madre Neoplásicas/patología , Osteoblastos/citología , Técnicas de Ablación , Animales , Antígenos CD/análisis , Médula Ósea/patología , Proteínas de Unión al Calcio/metabolismo , Ciclo Celular , Proliferación Celular , Células Cultivadas , Trasplante de Células Madre Hematopoyéticas , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Proteína Jagged-1 , Leucemia Mielógena Crónica BCR-ABL Positiva/metabolismo , Leucemia Mielógena Crónica BCR-ABL Positiva/terapia , Proteínas de la Membrana/metabolismo , Ratones , Ratones Transgénicos , Células Madre Neoplásicas/citología , Proteínas Serrate-Jagged
16.
Mol Vis ; 22: 734-47, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27440992

RESUMEN

PURPOSE: Increased lenticular oxidative stress and altered calcium/magnesium (Ca/Mg) homeostasis underlie cataractogenesis. We developed a liposomal formulation of magnesium taurate (MgT) and studied its effects on Ca/Mg homeostasis and lenticular oxidative and nitrosative stress in galactose-fed rats. METHODS: The galactose-fed rats were topically treated with liposomal MgT (LMgT), liposomal taurine (LTau), or corresponding vehicles twice daily for 28 days with weekly anterior segment imaging. At the end of the experimental period, the lenses were removed and subjected to analysis for oxidative and nitrosative stress, Ca and Mg levels, ATP content, Ca(2+)-ATPase, Na(+),K(+)-ATPase, and calpain II activities. RESULTS: The LTau and LMgT groups showed significantly lower opacity index values at all time points compared to the corresponding vehicle groups (p<0.001). However, the opacity index in the LMgT group was lower than that in the LTau group (p<0.05). Significantly reduced oxidative and nitrosative stress was observed in the LTau and LMgT groups. The lens Ca/Mg ratio in LMgT group was decreased by 1.15 times compared to that in the LVh group. Calpain II activity in the LMgT group was decreased by 13% compared to the LVh group. The ATP level and Na(+),K(+)-ATPase and Ca(2+)-ATPase activities were significantly increased in the LMgT group compared to the LVh group (p<0.05). CONCLUSIONS: Topical liposomal MgT delays cataractogenesis in galactose-fed rats by maintaining the lens mineral homeostasis and reducing lenticular oxidative and nitrosative stress.


Asunto(s)
Catarata/tratamiento farmacológico , Taurina/administración & dosificación , Taurina/uso terapéutico , Animales , Calcio/metabolismo , Calpaína/metabolismo , Catarata/metabolismo , Catarata/patología , Progresión de la Enfermedad , Galactosa , Homeostasis , Cristalino/efectos de los fármacos , Cristalino/metabolismo , Liposomas , Magnesio/metabolismo , Nitrosación , Estrés Oxidativo/efectos de los fármacos , Tamaño de la Partícula , Ratas Sprague-Dawley , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Taurina/química , Taurina/farmacología
17.
Exp Eye Res ; 143: 9-16, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26424219

RESUMEN

Steroid-induced hypertension and glaucoma is associated with increased extracellular meshwork (ECM) deposition in trabecular meshwork (TM). Previous studies have shown that single drop application of trans-resveratrol lowers IOP in steroid-induced ocular hypertensive (SIOH) rats. This IOP lowering is attributed to activation of adenosine A1 receptors, which may lead to increased matrix metalloproteinase (MMP)-2 activity. This study evaluated the effect of repeated topical application of trans-resveratrol for 21 days in SIOH animals on IOP, changes in MMP-2 level in aqueous humor, trabecular meshwork and retinal morphology and retinal redox status. We observed that treatment with trans-resveratrol results in significant and sustained IOP reduction in SIOH rats. This IOP reduction is associated with significantly higher aqueous humor total MMP-2 level; significantly reduced TM thickness and increased number of TM cells. Treatment with trans-resveratrol also significantly increased ganglion cell layer (GCL) thickness, the linear cell density in the GCL and inner retina thickness; and significantly reduced retinal oxidative stress compared to the SIOH vehicle-treated group. In conclusion, repeated dose topical application of trans-resveratrol produces sustained IOP lowering effect, which is associated with increased level of aqueous humor MMP-2, normalization of TM and retinal morphology and restoration of retinal redox status.


Asunto(s)
Antioxidantes/administración & dosificación , Modelos Animales de Enfermedad , Presión Intraocular/efectos de los fármacos , Hipertensión Ocular/tratamiento farmacológico , Retina/patología , Estilbenos/administración & dosificación , Malla Trabecular/patología , Administración Tópica , Animales , Humor Acuoso/enzimología , Recuento de Células , Femenino , Glucocorticoides/toxicidad , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Hipertensión Ocular/inducido químicamente , Hipertensión Ocular/enzimología , Hipertensión Ocular/patología , Soluciones Oftálmicas , Oxidación-Reducción , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Resveratrol , Células Ganglionares de la Retina/efectos de los fármacos , Tonometría Ocular
18.
Ulus Cerrahi Derg ; 32(3): 208-11, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27528814

RESUMEN

Truth or myth is seldom encountered in the practice of surgery, especially in cases of breast diseases. Yet, even after thousands of years of treating breast disease by surgeons/healers, fibroadenoma in the male breast seems to be a myth, due to the absence of fibro-glandular tissue. We wish to break this myth by our own experience as well as other studies by others all over the world, and unveil the truth that fibroadenoma in the male breast is a definitive entity and has a prevalence among the vast spectrum of breast diseases.

19.
Mol Vis ; 21: 612-20, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26019480

RESUMEN

INTRODUCTION: Elevated intraocular pressure (IOP) in glaucomatous eyes is often due to increased resistance to aqueous outflow. Previous studies have shown that increased extracellular material deposition in outflow pathways leads to increased resistance to aqueous outflow, and transforming growth factor (TGF)-ß seems to play a role in the deposition of extracellular material. TGF-ß2 is the predominant isoform in ocular tissue. Hence, comparison of the aqueous humor TGF-ß2 level between patients with open-angle glaucoma (OAG) and controls would provide direct evidence for the role of TGF-ß2 in the etiology of OAG. Hence, we performed this meta-analysis to develop an accurate estimate of the changes in aqueous humor TGF-ß2 levels among OAG patients. METHODS: We undertook the meta-analysis of data from all available studies that had a case-control design and investigated the aqueous humor levels of TGF-ß2 (total, active, or both) in OAG patients. OAG included primary OAG (POAG), secondary glaucoma, pseudoexfoliation syndrome, and exfoliation glaucoma (EXG). RESULTS: We selected a total of eight studies that measured TGF-ß2 levels in the aqueous humor of glaucomatous eyes. The studies included in this meta-analysis clearly demonstrated that in OAG eyes, total TGF-ß2 levels are significantly elevated, whereas in POAG eyes, both the total and active TGF-ß2 levels are significantly higher than in controls. CONCLUSIONS: The analysis of pooled data showed that aqueous humor TGF-ß2 levels are elevated in patients with OAG and POAG.


Asunto(s)
Humor Acuoso/metabolismo , Glaucoma de Ángulo Abierto/metabolismo , Factor de Crecimiento Transformador beta2/metabolismo , Estudios de Casos y Controles , Síndrome de Exfoliación/metabolismo , Glaucoma de Ángulo Abierto/etiología , Humanos , Presión Intraocular
20.
Clin Exp Ophthalmol ; 43(1): 54-66, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-24995479

RESUMEN

BACKGROUND: Steroid-induced ocular hypertension is currently treated in the same way as primary open-angle glaucoma. However, the treatment is often suboptimal and is associated with adverse effects. We evaluated the oculohypotensive effects of topical trans-resveratrol in rats with steroid-induced ocular hypertension and involvement of adenosine receptors (AR) in intraocular pressure (IOP) lowering effect of trans-resveratrol. METHODS: The oculohypotensive effect of unilateral single-drop application of various concentrations of trans-resveratrol was first studied in oculonormotensive rats. Concentration with maximum effect was similarly studied in rats with steroid-induced ocular hypertension. Involvement of AR was studied by observing the alterations of IOP in response to trans-resveratrol after pretreating animals with AR subtype-specific antagonists. Additionally, we used computational methods, including 3D modelling, 3D structure generation and protein-ligand interaction, to determine the AR-trans-resveratrol interaction. RESULTS: All concentrations of trans-resveratrol produced significant IOP reduction in normotensive rat eyes. Maximum mean IOP reduction of 15.1% was achieved with trans-resveratrol 0.2%. In oculohypertensive rats, trans-resveratrol 0.2% produced peak IOP reduction of 25.2%. Pretreatment with A1 antagonist abolished the oculohypotensive effect of trans-resveratrol. Pretreatment with A3 and A2A AR antagonists produced significant IOP reduction in both treated and control eyes, which was further augmented by trans-resveratrol application in treated eyes. Computational studies showed that trans-resveratrol has highest affinity for A2B and A1, followed by A2A and A3 AR. CONCLUSION: Topically applied trans-resveratrol reduces IOP in rats with steroid-induced ocular hypertension. Trans-resveratrol-induced oculohypotension involves its agonistic activity at the A1 AR.


Asunto(s)
Antihipertensivos/administración & dosificación , Antioxidantes/administración & dosificación , Presión Intraocular/efectos de los fármacos , Hipertensión Ocular/tratamiento farmacológico , Receptores Purinérgicos P1/fisiología , Estilbenos/administración & dosificación , Administración Tópica , Animales , Dexametasona/toxicidad , Modelos Animales de Enfermedad , Femenino , Glucocorticoides/toxicidad , Masculino , Hipertensión Ocular/inducido químicamente , Hipertensión Ocular/metabolismo , Soluciones Oftálmicas , Antagonistas de Receptores Purinérgicos P1/farmacología , Ratas , Ratas Sprague-Dawley , Resveratrol , Tonometría Ocular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA